| Piramal Life Sciences has reported a sales turnover of Rs 0.69 crore and a net loss of Rs 40.97 crore for the quarter ended Mar '11. | | For the quarter ended Mar 2010 the sales turnover was Rs 0.71 crore and net loss was Rs 33.44 crore. |
|
| | Quarterly Results of Piramal Life Sciences | -------- in Rs. Cr. -------- |
|
| Mar '10 | | | Dec '10 | Mar '11 | | Sales Turnover | 0.71 | | | 13.98 | 0.69 | | Other Income | -- | | | -- | -- | | Total Income | 0.71 | | | 13.98 | 0.69 | | Total Expenses | 31.19 | | | 26.30 | 27.03 | | Operating Profit | -30.48 | | | -12.32 | -26.34 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | -30.48 | | | -12.32 | -26.34 | | Interest | 6.95 | | | 10.46 | 11.77 | | PBDT | -37.43 | | | -22.78 | -38.11 | | Depreciation | 2.71 | | | 2.90 | 2.86 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | -40.14 | | | -25.68 | -40.97 | | Tax | -6.70 | | | -- | -- | | Net Profit | -33.44 | | | -25.68 | -40.97 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | -- | | | -- | -- | | Book Value | -- | | | -- | -- | | Equity | 25.45 | | | 25.45 | 25.45 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
